Forest Investigative Site 1314 — Norristown, Pennsylvania

Forest Investigative Site 1314 is a clinical research site located in Norristown, Pennsylvania, United States 19401.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Forest Investigative Site 1314 has participated in 1 clinical trials.

Therapeutic areas: Stage 1 Hypertension, Stage 2 Hypertension.

Sponsors: Forest Laboratories.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Norristown

Browse all research sites in Pennsylvania · View every site in Norristown

• Mercy Suburban Hospital and Cancer Center
• Suburban Community Hospital and Cancer Center
• Keystone Clinical Studies
• Luitpold Pharmaceuticals
• Novo Nordisk Investigational Site
• Research Site
• Pearl Clinical Research
• Pfizer Investigational Site
• Local Institution
• GSK Investigational Site
• US1124
• Dr. Cherian Verghese

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Forest Investigative Site 1314?

Forest Investigative Site 1314 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Forest Investigative Site 1314 conducted?

Forest Investigative Site 1314 has 1 clinical trials on record. Their work covers Stage 1 Hypertension, Stage 2 Hypertension.

Is Forest Investigative Site 1314 accredited by Crixeo Clinical Trials?

Forest Investigative Site 1314 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Forest Investigative Site 1314?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.